Item 5. Other Information
ITEM
5. OTHER INFORMATION
None.
38
ITEM
6. EXHIBITS
Incorporated
by Reference
Exhibit
Number
Exhibit
Description
Form
Exhibit
Filing
Date/Period End Date
2.1+
Amendment to Stock Purchase Agreement, dated as of February 4, 2023
8-K
2.1
2/10/2023
10.1
Loan and Security Agreement among LifeMD, Inc., Avenue Venture Opportunities Fund II, L.P. and Avenue Venture Opportunities Fund, L.P., dated March 21, 2023
8-K
10.1
3/23/2023
10.2
Supplement to Loan and Security Agreement among LifeMD, Inc., Avenue Venture Opportunities Fund II, L.P. and Avenue Venture Opportunities Fund, L.P., dated March 21, 2023
8-K
10.2
3/23/2023
10.3
Form of Warrant issued to Avenue Venture Opportunities
8-K
10.3
3/23/2023
10.4
Form of Promissory Note issued to Avenue Venture Opportunities
8-K
10.4
3/23/2023
10.5 #
Director Agreement, dated February 9, 2023 between LifeMD, Inc. and Joan LaRovere
8-K
10.1
2/10/2023
10.6 #
Restricted Stock Award Agreement, dated February 9, 2023, between LifeMD, Inc. and Joan LaRovere
8-K
10.2
2/10/2023
10.7 #
Non-Qualified Stock Option Agreement, dated February 9, 2023, between LifeMD, Inc. and Joan LaRovere
8-K
10.3
2/10/2023
31.1*
Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.
31.2*
Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.
32.1**
Section 1350 Certification of Chief Executive Officer.
32.2**
Section 1350 Certification of Chief Financial Officer.
101.INS*
Inline XBRL Instance Document
101.SCH*
Inline XBRL Taxonomy Extension Schema Document
101.CAL*
Inline XBRL Taxonomy Extension Calculation Linkbase
Document
101.DEF*
Inline XBRL Taxonomy Extension Definition Linkbase
Document
101.LAB*
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*
Inline XBRL Taxonomy Extension Presentation Linkbase
Document
104*
Cover Page Interactive Data File (formatted as Inline
XBRL and contained in Exhibit 101.INS)
+
Schedules and exhibits have been omitted. A copy of any omitted schedule or exhibit will be furnished supplementally to the SEC upon
its request.
#
Indicates management contract or compensatory plan, contract or arrangement.
*
Filed herewith.
**
Furnished herewith
39
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
LIFEMD,
INC.
By:
/s/
Justin Schreiber
Justin Schreiber
Chief Executive Officer and Chairman of the Board of
Directors
Date:
May 12, 2023
By:
/s/ Marc
Benathen
Marc Benathen
Chief Financial Officer
Date:
May 12, 2023
By:
/s/ Maria
Stan
Maria Stan
Principal Accounting Officer
Date:
May 12, 2023
40
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.